XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 3 Months Ended 9 Months Ended
Mar. 31, 2023
Apr. 01, 2022
Mar. 31, 2023
Apr. 01, 2022
Income Statement [Abstract]        
Revenue, net $ 2,803 $ 4,381 $ 9,646 $ 14,265
Cost of revenue 2,517 3,200 7,851 9,836
Gross profit 286 1,181 1,795 4,429
Operating expenses:        
Research and development 476 572 1,551 1,725
Selling, general and administrative 242 281 739 851
Employee termination, asset impairment, and other charges 40 4 140 24
Total operating expenses 758 857 2,430 2,600
Operating income (loss) (472) 324 (635) 1,829
Interest and other income (expense):        
Interest income 10 1 15 4
Interest expense (80) (75) (223) (229)
Other income, net 13 12 13 8
Total interest and other expense, net (57) (62) (195) (217)
Income (loss) before taxes (529) 262 (830) 1,612
Income tax expense 43 237 161 413
Net income (loss) (572) 25 (991) 1,199
Less: income attributable to preferred shareholders 9 0 9 0
Net income (loss) attributable to common shareholders $ (581) $ 25 $ (1,000) $ 1,199
Income (loss) per common share:        
Basic (in dollars per share) $ (1.82) $ 0.08 $ (3.14) $ 3.84
Diluted (in dollars per share) $ (1.82) $ 0.08 $ (3.14) $ 3.79
Weighted average shares outstanding:        
Basic (in shares) 319 313 318 312
Diluted (in shares) 319 316 318 316